Kenya has formally cleared the way to implement a $1.6 billion health cooperation agreement with the United States, ending months of legal uncertainty that had stalled one of the country’s most consequential bilateral health deals.
Treasury Principal Secretary Dr. Chris Kiptoo confirmed the agreement on 8 June 2026, following a courtesy call from US Chargé d’Affaires Susan Burns at the National Treasury. The announcement came weeks after the Court of Appeal lifted a High Court freeze on 12 May, allowing implementation to proceed.
“We have reached agreement on the implementation of the Kenya-US Health Cooperation Partnership, a five-year programme valued at US$1.6 billion,” Kiptoo said.
What the deal covers
The five-year programme, equivalent to Ksh207 billion, targets five areas: disease surveillance and outbreak response, laboratory systems strengthening, health commodities, frontline health workforce transition, and digital health systems.
The workforce component shifts US-funded health workers onto the Kenyan government payroll, advancing Universal Health Coverage. On the digital side, the programme funds a national rollout of electronic medical records and strengthens the data infrastructure underpinning Kenya’s health system.
Kiptoo also used the occasion to underscore the wider economic relationship. “US companies operating in Kenya continue to make a significant contribution to job creation, skills development, investment and economic growth, underscoring the strong economic ties between our two countries,” he said.
How the deal got frozen
The agreement has faced sustained resistance since it was first signed in December 2025 as part of a broader $2.5 billion Kenya-US Health Cooperation Framework. Within days of signing, the High Court issued a freeze citing serious constitutional concerns, and the US government voluntarily paused implementation in February 2026, saying it would respect the court process.
Critics came from multiple directions. Busia Senator Okiya Omtatah argued the executive signed a major international treaty without parliamentary approval or public participation. Consumer rights bodies, including the Consumers Federation of Kenya and the Katiba Institute, raised concerns that the deal could expose sensitive medical records, including HIV and TB data, to foreign access in violation of Kenya’s Data Protection Act.
Health rights organisation KELIN went further, warning that full legal immunity granted to US personnel and contractors placed American firms beyond the reach of Kenyan courts in the event of any data misuse. Critics also flagged that the deal obligates Kenya to contribute an additional Ksh110 billion of taxpayer funds toward US-approved health priorities over the five-year period.
What the government says on data
Susan Burns addressed the data concerns directly when the deal was first announced. “The government of Kenya will continue to abide by its privacy laws. We are just putting on paper the similar policies that we have followed for many years, and any data-sharing going forward will be aggregated,” she said.
Kenya’s Data Protection Act and Digital Health Act classify health information as sensitive personal data. Any cross-border data transfer requires a lawful basis, adequate safeguards, and oversight by the Office of the Data Protection Commissioner. Nothing in the framework overrides those protections.
How the freeze was lifted
The Court of Appeal’s three-judge bench sided with the government’s argument that the High Court freeze was opening a dangerous gap in public health services. That ruling on 12 May cleared the path to implementation, though the underlying constitutional questions raised by civil society have not fully closed.
